Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News

Icon

Non-invasive neurotechnology: What’s next in research and clinical applications

Enjoy these great pre­sen­ta­tions on the future of non-invasive neu­rotech, deliv­ered at the 2014 Sharp­Brains Vir­tual Sum­mit and featuring:

  • Dr. Bruce Cuth­bert, Direc­tor of Adult Trans­la­tional Research and Treat­ment Devel­op­ment at the NIMH
  • Charles Fisher, Pres­i­dent of Fisher Wal­lace Laboratories
  • Chair: James Cavuoto, Edi­tor and Pub­lisher at Neu­rotech Reports

Dr. Thomas Insel, NIMH Director, to speak @ 2014 SharpBrains Virtual Summit

Tom InselWe are proud to share that Dr. Thomas Insel, Direc­tor of the National Insti­tute of Men­tal Health and neu­rotech­nol­ogy vision­ary, will open the 2014 Sharp­Brains Vir­tual Sum­mit on Tues­day, Octo­ber 28th.

Prior to this appoint­ment at NIMH, Dr. Insel was Pro­fes­sor of Psy­chi­a­try at Emory Uni­ver­sity, where he was found­ing direc­tor of the Cen­ter for Behav­ioral Neu­ro­science. He has pub­lished over 250 sci­en­tific arti­cles and four books, served on numer­ous aca­d­e­mic, sci­en­tific, and pro­fes­sional com­mit­tees and boards, and is a recip­i­ent of sev­eral awards, includ­ing the Out­stand­ing Ser­vice Award from the U.S. Pub­lic Health Ser­vice. Dr. Insel grad­u­ated from the com­bined B.A.-M.D. pro­gram at Boston Uni­ver­sity, did his intern­ship at Berk­shire Med­ical Cen­ter, Mass­a­chu­setts, and his res­i­dency at the Lan­g­ley Porter Neu­ropsy­chi­atric Insti­tute at the Uni­ver­sity of Cal­i­for­nia, San Francisco.

–> Explore the Agenda at 2014 Sharp­Brains Vir­tual Sum­mit, and con­sider join­ing us Octo­ber 28-30th!

Good profile of pioneer Dr. Thomas Insel, NIMH Director

ThomasInselBlaz­ing Trails in Brain Sci­ence (The New York Times):

The pen­du­lum has swung so far toward drug ther­apy in recent years that it is hard to recap­ture how dis­rup­tive those 1980 stud­ies were. Dr. Insel’s work and that of many oth­ers, test­ing the effect of new med­ica­tions, would turn the field away from long-term talk­ing cures and increas­ingly toward med­ica­tion and short-term behav­ior ther­a­pies rooted in the same kind of ran­dom­ized, con­trolled tri­als con­ducted in other fields of medicine…Yet the over­all impact of this drug rev­o­lu­tion on pub­lic health has been mixed…”

To Learn More:

Time to revamp psychiatry and mental health in light of modern neuroscience?

mentalhealthpuzzleTrans­form­ing Diag­no­sis (arti­cle by Thomas Insel, Direc­tor of the NIMH): “In a few weeks, the Amer­i­can Psy­chi­atric Asso­ci­a­tion will release its new edi­tion of the Diag­nos­tic and Sta­tis­ti­cal Man­ual of Men­tal Dis­or­ders (DSM-5)…While DSM has been described as a “Bible” for the field, it is, at best, a dic­tio­nary, cre­at­ing Read the rest of this entry »

Maximizing brain fitness and mental well-being improves both public health and individual quality of life

 We’re hav­ing a good con­ver­sa­tion among Sharp­Brains Sum­mit par­tic­i­pants, prompted by the blog post Life­long brain well­ness and performance–not med­ical disease–drives grow­ing demand for dig­i­tal brain health solu­tions. In what is a beau­ti­ful exam­ple of the need to see both the for­est and the trees Read the rest of this entry »

Transcript: Online Q&A on the Future of Brain Health with Alvaro Fernandez

Below you can find the full tran­script of our engag­ing Q&A ses­sion today, Fri­day March 16th, on brain sus­tain­abil­ity, retool­ing brain health, and applied neu­ro­plas­tic­ity, with Alvaro Fer­nan­dez, Sharp­Brains’ Co-Founder who’s just been named a Young Global Leader by the World Eco­nomic Forum. You can learn more about the topic by read­ing this 2011 Sharp­Brains Sum­mit Meet­ing Report and this Info­graphic.

10:04
Great, we are ready to start!  Read the rest of this entry »

Personalized Medicine in Psychiatry: from DSM to brain-based RDoC, iSPOT-D and biomarkers

(Editor’s Note: this is Part 2 of the new 3-part series writ­ten by Dr. Evian Gor­don draw­ing from his par­tic­i­pa­tion at the Per­son­al­ized Med­i­cine World Con­gress on Jan­u­ary, 23, 2012 at Stan­ford University.)

Most Per­son­al­ized Med­i­cine research in Psy­chi­a­try using mol­e­c­u­lar mea­sures alone have failed to repli­cate. Whilst dis­ap­point­ing, this is not sur­pris­ing, since 80% of human 25,000 genes have some effect on the brain.

There are there­fore grow­ing efforts expand­ing Genomic Bio­mark­ers in Psy­chi­a­try to Neu­roimag­ing (all Brain-based bio­log­i­cal and cog­ni­tive mea­sures). Some approaches tar­get Read the rest of this entry »

Welcome to SharpBrains.com

As seen in The New York Times, The Wall Street Jour­nal, CNN and more, Sharp­Brains is an inde­pen­dent mar­ket research firm track­ing health and well­ness appli­ca­tions of brain science.
FIRST-TIME VISITOR? Dis­cover HERE the most pop­u­lar resources at SharpBrains.com

Follow us via

twitter_logo_header

Gold Sponsors @ 2014 SharpBrains Virtual Summit (October 28-30th)

Enter Your Email to receive Sharp­Brains free, monthly eNewslet­ter:
Join more than 50,000 Sub­scribers and stay informed and engaged.